SC2i is proud to count among its leadership, researchers and surgeons from premier military and civilian critical-care centers.
Eric A. McElster, MD, FACS
Professor and Chairman, Norman M. Rich Department of Surgery, Uniformed Services University of the Health Sciences
Dr. Elster received his undergraduate and medical school degrees from the University of South Florida in Tampa as a recipient of the U.S. Navy’s Health Professionals Scholarship Program. Upon graduation, Dr. Elster completed a general surgery residency at the National Naval Medical Center in Bethesda, MD. During Operation Iraqi Freedom, Dr. Elster served as ship’s surgeon aboard the USS Kitty Hawk while stationed in the Persian Gulf. Upon returning, Dr. Elster completed a solid organ transplantation fellowship at the National Institutes of Health. CAPT Elster now serves as the 3rd Chairman of the Norman M. Rich Department of Surgery at the Uniformed Services University of the Health Sciences. Dr. Elster was recently deployed as a surgeon and Director of Surgical Services at the NATO Role 3 Military Medical Unit in Kandahar, Afghanistan. Dr. Elster is a member of numerous organizations including a fellow of the American College of Surgeons, Society of University Surgeons,American Society of Transplant Surgeons, and has published over 100 scientific manuscripts and received numerous research grants.
Allan D. Kirk, MD, PhD, FACS
Chairman, Department of Surgery, Duke University School of Medicine and Surgeon-in-Chief, Duke University Health System
Allan D. Kirk, MD, PhD is the Chairman of Surgery at Duke University and the Surgeon-in-Chief of the Duke University Health System. He is a practicing kidney and pancreas transplant surgeon and is a recognized authority in organ transplantation and its related immunology. He is the Editor-in-Chief of the American Journal of Transplantation and maintains an active basic research and clinical trial portfolio with a scientific bibliography of over 200 original manuscripts. His interests include the fundamental relationships between injury, critical illness and immune function and is a founding investigator of the SC2i. He currently serves as the Principal Investigator for the SC2i at Duke University and oversees the SC2i's civilian investigative partnerships.
Benjamin K. Potter, MD
Vice-Chairman for Research, Norman M. Rich Department of Surgery, Uniformed Services University of the Health Sciences
LTC Benjamin “Kyle” Potter is a Deputy Director of SC2i. Dr Potter is an Honor graduate of the United States Military Academy at West Point and an Alpha Omega Alpha graduate of the University of Chicago, Pritzker School of Medicine. He completed his orthopaedic surgery residency at the former Walter Reed Army Medical Center and a musculoskeletal oncology fellowship at the University of Miami. LTC Potter deployed to Afghanistan in 2011, serving as the Chief Orthopaedic Surgeon for the Task Force 115 Combat Support Hospital, Camp Dwyer, Helmand Province. In addition to his SC2i duties, Dr. Potter currently serves as the Vice Chair (Research) & Associate Professor in the Department of Surgery at the Uniformed Services University. He is also the Chief Orthopaedic Surgeon for the Amputee Program and the Director of Musculoskeletal Oncology at WRNMMC, and a musculoskeletal oncology consultant for the NCI/NHLBI at the NIH. Dr. Potter serves on numerous orthopaedic journal editorial boards and has published over 100 peer-reviewed manuscripts. In addition to stated goals of the SC2i program, his other personal research interests include amputation surgery, heterotopic ossification, and the management of primary and metastatic disease of bone.
Jonathan A. Forsberg, MD
Department Head of Regenerative Medicine, Naval Medical Research Center
Dr. Jonathan A. Forsberg began his military career as a Marine Corps infantryman. He obtained a bachelor's degree in chemistry from the U.S. Naval Academy in Annapolis, MD and graduated from F. Edward Hébert School of Medicine. He completed an orthopaedic surgery residency at the National Naval Medical Center in Bethesda MD, followed by an orthopaedic oncology fellowship at the Memorial Sloan-Kettering Cancer Center in New York City.
Today, Dr. Forsberg is an active clinician scientist and Naval Officer. He serves as the Regenerative Medicine Department Head at the Naval Medical Research Center in Silver Spring, MD. There, as part of a collaborative group, he oversees DoD funded combat casualty research and mentors orthopaedic residents in translational research. He spends the balance of his time engaged in the treatment of combat-related orthopaedic injuries at the Walter Reed National Military Medical Center while maintaining a busy orthopaedic oncology practice at the John Murtha Cancer Center and National Cancer Institute located in Bethesda MD.
His research efforts are geared towards the characterization and prevention of combat-related heterotopic ossification, developing osseointegrated solutions for amputees and applying personalized medicine to extremity surgery using advanced bioinformatics approaches.
Dr. Forsberg is a Diplomate of the American Board of Orthopaedic Surgery. He is a member of the American Academy of Orthopaedic Surgeons, the Musculoskeletal Tumor Society, the International Society of Limb Salvage, the Orthopaedic Surgery Osseointegration Society, the Swedish Orthopaedic Society and the Society of Military Orthopaedic Surgeons.
Timothy G. Buchman, PhD, MD, FACS, FCCP, MCCM
Founding Director, Emory Critical Care Center
Timothy G. Buchman, PhD, MD, FACS, FCCP, MCCM is the founding director of the Emory’s Critical Care Center, which integrates throughout the Emory Healthcare system. The Center assembles clinicians, teachers and investigators from diverse disciplines to deliver the Right Care, Right Now, Every Time. Dr. Buchman is past president of the Shock Society, the Society for Complex Acute Illness and the Society of Critical Care Medicine, the latter being the largest organization of critical care professionals worldwide.
Before joining Emory, he served as the Edison Professor of Surgery and Director of Acute and Critical Care Surgery at Washington University in St. Louis. Prior to his 15 years on the faculty at Washington University, Dr. Buchman directed the surgical intensive care unit and founded the trauma service at Johns Hopkins Hospital in Baltimore, where he completed his surgical training..
Dr. Buchman's research has spanned the bench-to-bedside continuum, including NIH-funded studies of physiological dynamics; of patient monitoring; of the genetics of sepsis and of ICU end-of-life care. His current activity focuses on promoting situation awareness and using predictive analytics in critical care to achieve better health, better care and lower costs.
Christopher J. Dente, MD, FACS
Associate Professor of Surgery, Emory University School of Medicine
Having completed surgical residency at Wayne State University in 2002 and Surgical Critical Care training at Emory in 2004 and achieving board certification in both specialties, Dr. Dente has been on Emory’s faculty at Grady Memorial Hospital since 2004. While he maintains a very active clinical practice in trauma and general surgery at Atlanta’s premier level I trauma centers, he has also published multiple manuscripts on a variety of topics in acute care surgery and trauma, with a recent focus on the design and implementation of a Massive Transfusion Protocol. He maintains a national presence as the Vice Chair of the American Association for Surgery of Trauma’s Acute Care Surgery Committee and the chair of the Georgia Chapter of the American College of Surgeons.
Rebecca L. Scotland, Ph.D.
Molecular Biology & Information Decision Analyst, DecisionQ Corporation
Dr. Scotland earned a B.S. in Chemistry and Mathematics in 2001 and a Ph.D. from the University Of Kentucky College Of Medicine in Biomedical and Molecular Pharmacology with an emphasis in adaptive and maladaptive physiological signaling pathways in 2006. She completed a post-doctoral fellowship in 2010, in the Department of Cardiology at the University of Minnesota, focused on mechanisms of regeneration and stem cell biology. She went on to lead the start-up laboratory at Transposagen Biopharmaceuticals developing novel genetic technologies, acquired for CAR-T cancer therapies by Johnson & Johnson’s Janssen in 2015. She has since fulfilled regulatory consulting and business development roles for multinational corporations. Most recently, she joined DecisionQ in May 2015 to leverage their substantial analytic capabilities to improve healthcare and patient outcomes. She is committed to finding health and wellness solutions using innovative approaches in biotechnology.
Arnaud J. Belard, MBA
Administrative Director, Henry M. Jackson Foundation for the Advancement of Military Medicine
Arnaud Belard, MBA, received his undergraduate and graduate degrees from West Virginia University, Morgantown WV. Upon graduation, he returned to his home country of France to meet his military obligation. Honorably discharged after his year-long service, Mr. Belard returned to the United States and accepted a post as Attaché for Trade Policy at the Embassy of France in 1997. In 2002, Mr. Belard moved to Kyoto Japan, where he co-established Bizyme Inc, a management-consulting activity focused on small and medium-sized enterprises. Mr. Belard returned to the Washington DC area in 2005, joining the Henry M. Jackson Foundation for the Advancement of Military Medicine as Executive Director for the Proton Beam Program (Walter Reed Army Medical Center, then Walter Reed National Military Medical Center). In 2014, he assumed the role of Administrative Director for the newly established Surgical Critical Care Initiative (a Uniformed Services University of the Health Sciences – Henry M. Jackson Foundation for the Advancement of Military Medicine research program).
Mr. Belard has published in telemedicine and oncology journals and was a peer-reviewer for the journal of Telemedicine and eHealth. He received the Commander’s Award for Public Service – Department of the Army in 2010.